These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9715413)

  • 21. Choleretic effects of ursodeoxycholic acid on experimentally-induced intrahepatic cholestasis.
    Mizoguchi Y; Miyajima K; Kioka K; Seki S; Kobayashi K; Morisawa S
    Osaka City Med J; 1989 Nov; 35(2):83-91. PubMed ID: 2628845
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Positive effect of ursodeoxycholic acid on liver enzymes in autoimmune hepatitis with little activity--a pilot study].
    Janowitz P; Kratzer W; Wechsler JG
    Leber Magen Darm; 1996 Nov; 26(6):310-3. PubMed ID: 9082112
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ursodeoxycholic acid for primary biliary cirrhosis: treat early to slow progression.
    Paumgartner G
    J Hepatol; 2003 Jul; 39(1):112-4. PubMed ID: 12821052
    [No Abstract]   [Full Text] [Related]  

  • 24. Ursodeoxycholic acid for primary biliary cirrhosis: lessons from the past--issues for the future.
    Poupon RE
    J Hepatol; 2000 Apr; 32(4):685-8. PubMed ID: 10782919
    [No Abstract]   [Full Text] [Related]  

  • 25. Ursodeoxycholic acid as a supplementary treatment in corrected biliary atresia.
    Smaropoulos EC; Kaselas B
    Eur J Pediatr Surg; 2006 Apr; 16(2):138-9. PubMed ID: 16685625
    [No Abstract]   [Full Text] [Related]  

  • 26. Looking Into the Crystal Ball: Predicting Non-response to Ursodeoxycholic Acid in Primary Biliary Cholangitis.
    Zimmer V; Lammert F
    EBioMedicine; 2017 Feb; 15():10-11. PubMed ID: 28007481
    [No Abstract]   [Full Text] [Related]  

  • 27. [Chologonic and choleretic action of the Soviet preparation xylite].
    Grancharov VP
    Vopr Pitan; 1971; 30(6):18-20. PubMed ID: 5131655
    [No Abstract]   [Full Text] [Related]  

  • 28. Ursodeoxycholic acid for the treatment of primary biliary cirrhosis.
    Lindor K
    N Engl J Med; 2007 Oct; 357(15):1524-9. PubMed ID: 17928600
    [No Abstract]   [Full Text] [Related]  

  • 29. Ursodeoxycholic acid in chronic hepatitis C.
    Poupon R; Serfaty L
    Gut; 2007 Dec; 56(12):1652-3. PubMed ID: 17998321
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ursodeoxycholic acid and long-term survival in primary biliary cirrhosis.
    Levy C; Angulo P
    Am J Gastroenterol; 2004 Feb; 99(2):269-70. PubMed ID: 15046216
    [No Abstract]   [Full Text] [Related]  

  • 31. Pregnancy in women with ursodeoxycholic acid-treated primary biliary cirrhosis.
    Poupon R; Chrétien Y; Chazouillères O; Poupon RE
    J Hepatol; 2005 Mar; 42(3):418-9. PubMed ID: 15710226
    [No Abstract]   [Full Text] [Related]  

  • 32. The ursodeoxycholic acid story in primary biliary cirrhosis.
    Lim AG; Jazrawi RP; Northfield TC
    Gut; 1995 Sep; 37(3):301-4. PubMed ID: 7590420
    [No Abstract]   [Full Text] [Related]  

  • 33. The long-term beneficial effects of ursodeoxycholic acid in primary biliary cirrhosis are highly questionable.
    Yan G; Erik C; Gluud C
    Am J Gastroenterol; 2007 Feb; 102(2):464-5. PubMed ID: 17311669
    [No Abstract]   [Full Text] [Related]  

  • 34. Use of ursodeoxycholic acid in liver diseases.
    Kumar D; Tandon RK
    J Gastroenterol Hepatol; 2001 Jan; 16(1):3-14. PubMed ID: 11206313
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Modern approaches to the treatment of biliary pathology in young patients with obesity].
    Khismatullina GIa; Volevach LV; Khakamova GA; Uliamaeva VV; Bychenkova MA
    Eksp Klin Gastroenterol; 2012; (4):60-5. PubMed ID: 23402156
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Indications and contraindications of choleretic therapy].
    Grossi F
    Clin Ter; 1974; 70(2):108-9. PubMed ID: 4409826
    [No Abstract]   [Full Text] [Related]  

  • 37. The effect of ursodeoxycholic acid in children with prolonged hepatitis A virus infection that may be a trigger factor for autoimmune hepatitis.
    Koçak N; Saltik IN
    Am J Gastroenterol; 2001 Feb; 96(2):610-1. PubMed ID: 11232728
    [No Abstract]   [Full Text] [Related]  

  • 38. [The chologenic and choleretic action of sorbitol].
    Grancharov V
    Vopr Pitan; 1973; 32(2):50-4. PubMed ID: 4782923
    [No Abstract]   [Full Text] [Related]  

  • 39. [Choleretic effect of Bulgarian rose oil].
    Tashev TA; Belousov AS; Gryneharov VP; Zhigalova MF
    Klin Med (Mosk); 1970 Aug; 48(8):57-61. PubMed ID: 5476044
    [No Abstract]   [Full Text] [Related]  

  • 40. Treatment of primary biliary cirrhosis: therapy with choleretic and immunosuppressive agents.
    Silveira MG; Lindor KD
    Clin Liver Dis; 2008 May; 12(2):425-43; x-xi. PubMed ID: 18456189
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.